首页 | 本学科首页   官方微博 | 高级检索  
   检索      

Exendin-4类似物的克隆、表达与体内生物活性检测
引用本文:李泰明,谷春娇,葛晓宇,李哲哲,王丹,马艳红,刘涛,张美由,李丽,刘景晶.Exendin-4类似物的克隆、表达与体内生物活性检测[J].生物工程学报,2012,28(7):877-886.
作者姓名:李泰明  谷春娇  葛晓宇  李哲哲  王丹  马艳红  刘涛  张美由  李丽  刘景晶
作者单位:中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009;中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009
基金项目:国家高技术研究发展计划(863计划) (No. 2202AA217031-2), 国家自然科学基金 (No. 30270298), 江苏省自然科学基金 (Nos. BK95092309, BG2001011), 国家基础科学人才培养基金 (No. J0630858) 资助。
摘    要:为研究Exendin-4类似物的克隆,融合表达及在体内的生物活性,在pED载体融合伴侣序列中插入利于下游分离纯化的序列成为5#载体,将Exendin-4类似物基因与5#载体中的融合伴侣基因通过酸水解位点连接,转化至E.coli BL21中并诱导表达融合蛋白,酸水解将目的肽与融合伴侣分开后,经阴离子交换树脂分离得到目的肽。6周~8周正常雄性ICR小鼠皮下注射Exendin-4类似物后,口服糖耐量实验检测在不同时间段小鼠血液中葡萄糖及胰岛素含量的变化。结果表明:融合蛋白的表达量占菌体总蛋白的40%,Exendin-4类似物纯度达91.8%。Exendin-4类似物的活性与对照组相比,具有显著的降低血糖和显著促进胰岛素分泌的活性(P<0.01)。

关 键 词:Exendin-4类似物  生物活性  血糖  胰岛素
收稿时间:2011/11/27 0:00:00

Cloning, expressing of Exendin-4 analogue and bioactivity analysis in vivo
Taiming Li,Chunjiao Gu,Xiaoyu Ge,Zhezhe Li,Dan Wang,Yanhong M,Tao Liu,Meiyou Zhang,Li Li and Jingjing Liu.Cloning, expressing of Exendin-4 analogue and bioactivity analysis in vivo[J].Chinese Journal of Biotechnology,2012,28(7):877-886.
Authors:Taiming Li  Chunjiao Gu  Xiaoyu Ge  Zhezhe Li  Dan Wang  Yanhong M  Tao Liu  Meiyou Zhang  Li Li and Jingjing Liu
Institution:State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
Abstract:To construct,express and purify Exendin-4 analogue and detect its biological activity in vivo.Insert gene sequence into fusion partner of pED plasmid which is helped to purification,entitled the new recombinant plasmid 5#.Exendin-4 analogue polypeptide gene and fusion partner gene was linked by acid hydrolysis gene,transformed to E.coli BL21 and the fusion protein was induced by lactose.after acid hydrolysis,the Exendin-4 analogue polypeptide separated from fusion chaperon.Anion charge chromatography were used to further purification.6 to 8 week-old ICR mice were injected(s.c) with Exendin-4 analogue,blood glucose and plasma insulin level was detected in different period after oral glucose tolerance test.The results show that high expression of inclusion body was induced by lactose,which accounted for 40% of germ proteins,the Exendin-4 analogue was obtained with the purity of 91.8% after being purified by anion charge chromatography.Bioactivity assay showed that the level of blood glucose of mouse which treated with exendin-4 analogue was obviously decreased to normal(P<0.01),and the level of plasma insulin was increased obviously(P<0.01).
Keywords:Exendin-4 analogue  bioactivity  blood glucose  plasma insulin
本文献已被 CNKI 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号